JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-01-20 1209f8e0m50(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0
经验分享：还是蛮容易接收的，建议也不是很多，很友好

237 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-02-11 x点诱1995 来自上海

审稿速度:3.0 | 投稿命中率:75.0
经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。

46 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2013-06-22 albertang

审稿速度:3.0 | 投稿命中率:75.0
经验分享：还好, 临床的容易发...

457 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2016-08-13 ms4354791198256231

审稿速度:4.0
经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。

141 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-02-17 ms5000001996918480 来自江苏省

请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？

50 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-08-15 1465389cm38暂无昵称

中了第二篇，但不建议多投，中科院3区，意义不大

79 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-01-26 SALAZAR

2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢

128 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-03-22 嘟嘟啦啦啦来自辽宁省

editor assigned 2周了，啥时候能外审那

6 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-01-13 ms9000002137545467 来自广东省

审稿速度:12.0 | 投稿命中率:5.0
经验分享：傅

15 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114146, encodeId=c37c211414674, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：第二篇被再次接受，2022.11.3投稿，2023.2.9号被接受，期间也只经历过一次修改。个人体会：连续发的2篇都是临床类型文章，只要有一定创新点，逻辑严密，感觉很好发。两篇文章意见都给的大修，但只要态度诚恳，仔细认真修改并一条条回复，一般问题都不大。第二篇在编辑手上呆了很长时间（约4W），发了一封催稿件后立马送外审（着急的小伙伴可以适当发催稿信提醒下编辑）。连中2篇，下次应该也不会再投这个杂志了。希望上述帮到各位小伙伴。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eNX8UB9y7EfaHAm8FLh8tMnf0YtibHkWJHfMibHPmFvCrdhuc5nYllP3aFKPALqoXYl7MPpVJEc278S2ejoetKfQ/132, createdBy=aca32172258, createdName=x点诱1995, createdTime=Sat Feb 11 19:40:11 CST 2023, time=2023-02-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=496650, encodeId=ffa6496650b6, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：还好, 临床的容易发..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fb749378, createdName=albertang, createdTime=Sat Jun 22 20:23:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115168, encodeId=7c892115168e3, content=请问从投稿第二天的editor assigned到第三天under review是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Fri Feb 17 23:09:37 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194598, encodeId=0ecb21945980c, content=editor assigned 2周了，啥时候能外审那, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Fri Mar 22 04:27:17 CST 2024, time=2024-03-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2181221, encodeId=c7f1218122100, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：傅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818f8153055, createdName=ms9000002137545467, createdTime=Sat Jan 13 13:33:35 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

文章投稿应该按照什么思路开始？

62 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务